HIMS Plummets 5.69% on $2.5B Surge in Volume Ranks 25th in Market Activity

. 16, 2025, . The stock’s sharp drop followed a mix of earnings-related concerns and sector-specific headwinds.

Analysts noted that HIMS’s performance was influenced by investor caution ahead of its upcoming , with short-term traders rotating into defensive assets. Additionally, broader market volatility in healthcare technology stocks pressured the company’s valuation, despite its recent product launch in men’s wellness services. Institutional selling pressure was observed in midday trading, amplifying the downward momentum.

For the back-test scenario: To replicate the strategy, the universe must be defined as either all U.S.-listed equities or a subset like the S&P 500. Rebalancing parameters require clarification—whether the portfolio is re-formed daily at close and liquidated the next day, with equal weighting across holdings. Given the system’s constraints, a proxy approach using the 500 most-liquid S&P 500 stocks or an ETF alternative may be necessary to aggregate results accurately.